HealthEquity (NASDAQ:HQY) Hits New 1-Year Low – Here’s What Happened

HealthEquity, Inc. (NASDAQ:HQY) reached a new 52-week low during trading on Thursday . The stock traded as low as $73.63 and last traded at $74.5150, with a volume of 751359 shares changing hands. The stock had previously closed at $76.92.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on the company. Citizens Jmp increased their price objective on HealthEquity from $117.00 to $122.00 and gave the stock a “market outperform” rating in a report on Thursday, December 4th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of HealthEquity in a research note on Thursday, January 22nd. Wall Street Zen upgraded shares of HealthEquity from a “hold” rating to a “buy” rating in a research note on Monday, January 19th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a $120.00 target price on shares of HealthEquity in a research note on Friday, December 5th. Finally, JMP Securities set a $122.00 price target on HealthEquity in a report on Thursday, December 4th. Two analysts have rated the stock with a Strong Buy rating, twelve have issued a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $119.60.

HealthEquity Price Performance

The stock has a market capitalization of $6.31 billion, a P/E ratio of 33.89, a price-to-earnings-growth ratio of 0.91 and a beta of 0.24. The company has a debt-to-equity ratio of 0.46, a quick ratio of 4.13 and a current ratio of 4.13. The stock has a 50-day simple moving average of $88.39 and a 200 day simple moving average of $92.30.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings results on Wednesday, December 3rd. The company reported $1.01 earnings per share for the quarter, beating analysts’ consensus estimates of $0.90 by $0.11. HealthEquity had a return on equity of 12.94% and a net margin of 14.86%.The company had revenue of $322.16 million for the quarter, compared to the consensus estimate of $320.92 million. During the same quarter in the prior year, the business posted $0.78 EPS. The firm’s quarterly revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. On average, equities analysts forecast that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

Insider Transactions at HealthEquity

In related news, EVP Elimelech Rosner sold 10,959 shares of the company’s stock in a transaction dated Thursday, December 18th. The shares were sold at an average price of $95.45, for a total value of $1,046,036.55. Following the transaction, the executive vice president owned 45,742 shares in the company, valued at approximately $4,366,073.90. This represents a 19.33% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Delano Ladd sold 1,500 shares of the firm’s stock in a transaction on Friday, December 19th. The stock was sold at an average price of $94.72, for a total value of $142,080.00. Following the completion of the transaction, the executive vice president owned 73,979 shares in the company, valued at $7,007,290.88. The trade was a 1.99% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 13,959 shares of company stock valued at $1,344,957 in the last quarter. 1.50% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On HealthEquity

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Acumen Wealth Advisors LLC bought a new stake in shares of HealthEquity in the fourth quarter valued at $27,000. Caitong International Asset Management Co. Ltd raised its position in shares of HealthEquity by 1,723.5% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock worth $28,000 after buying an additional 293 shares in the last quarter. True Wealth Design LLC boosted its position in shares of HealthEquity by 3,522.2% during the 3rd quarter. True Wealth Design LLC now owns 326 shares of the company’s stock valued at $31,000 after acquiring an additional 317 shares during the last quarter. Cullen Frost Bankers Inc. grew its stake in HealthEquity by 172.3% in the 2nd quarter. Cullen Frost Bankers Inc. now owns 354 shares of the company’s stock worth $37,000 after buying an additional 224 shares in the last quarter. Finally, Farther Finance Advisors LLC increased its position in shares of HealthEquity by 59.3% during the 3rd quarter. Farther Finance Advisors LLC now owns 392 shares of the company’s stock valued at $37,000 after purchasing an additional 146 shares during the last quarter. Hedge funds and other institutional investors own 99.55% of the company’s stock.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.